Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Harte-Hanks
HHS
$20.8M
| $471K | ﹤0.01% |
86,000
-7,100
| -8% | -$48.3K |
|
|
OPOF
2902
DELISTED
Old Point Financial
OPOF
| $471K | ﹤0.01% |
27,135
+4,300
| +19% | +$80.1K |
|
|
RBOT
2903
DELISTED
Vicarious Surgical
RBOT
| $471K | ﹤0.01% |
8,577
-236
| -3% | -$15K |
|
|
COE
2904
51Talk Online Education Group
COE
$124M
| $468K | ﹤0.01% |
52,575
| – | – |
|
2905
MainStreet Bancshares
MNSB
$179M
| $468K | ﹤0.01% |
20,649
-25,251
| -55% | -$553K |
|
2906
OneWater Marine
ONEW
$203M
| $467K | ﹤0.01% |
+12,900
| New | +$381K |
|
2907
MBIA
MBI
$262M
| $466K | ﹤0.01% |
53,974
-76,400
| -59% | -$688K |
|
|
RDNW
2908
RideNow Group
RDNW
$241M
| $466K | ﹤0.01% |
+37,700
| New | +$352K |
|
|
TERN
2909
DELISTED
Terns Pharmaceuticals
TERN
| $466K | ﹤0.01% |
53,200
-52,000
| -49% | -$606K |
|
|
AVNS
2910
DELISTED
Avanos Medical
AVNS
| $465K | ﹤0.01% |
18,200
-14,300
| -44% | -$377K |
|
|
EXPR
2911
DELISTED
Express, Inc.
EXPR
| $465K | ﹤0.01% |
39,165
-10,565
| -21% | -$153K |
|
|
EMX
2912
DELISTED
EMX Royalty
EMX
| $464K | ﹤0.01% |
244,126
+59,967
| +33% | +$117K |
|
2913
Vanguard Energy ETF
VDE
$10.4B
| $463K | ﹤0.01% |
4,100
+1,000
| +32% | +$113K |
|
|
XXII
2914
22nd Century Group
XXII
$1.42M
| – | – |
0
| – | – |
|
2915
Advantage Solutions
ADV
$423M
| $460K | ﹤0.01% |
7,871
+379
| +5% | +$16.2K |
|
2916
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
| $459K | ﹤0.01% |
+3,000
| New | +$468K |
|
2917
Cardiff Oncology
CRDF
$76.6M
| $458K | ﹤0.01% |
311,290
-20,018
| -6% | -$32.3K |
|
2918
Coffee Holding Co
JVA
$20.2M
| $458K | ﹤0.01% |
329,164
-6,100
| -2% | -$10.1K |
|
2919
Neonode
NEON
$14.8M
| $457K | ﹤0.01% |
56,600
-9,400
| -14% | -$70.1K |
|
|
MTA
2920
Metalla Royalty & Streaming
MTA
$848M
| $456K | ﹤0.01% |
105,100
+57,085
| +119% | +$273K |
|
2921
ePlus
PLUS
$2.31B
| $456K | ﹤0.01% |
8,108
-52,892
| -87% | -$2.61M |
|
|
MAGN
2922
Magnera Corp
MAGN
$433M
| $455K | ﹤0.01% |
11,592
-923
| -7% | -$41.8K |
|
2923
Emerson Radio
MSN
$7.99M
| $453K | ﹤0.01% |
767,888
-8,500
| -1% | -$4.69K |
|
2924
Sonida Senior Living
SNDA
$1.88B
| $453K | ﹤0.01% |
51,991
-300
| -0.6% | -$2.37K |
|
2925
Fidelity MSCI Utilities Index ETF
FUTY
$2.31B
| $452K | ﹤0.01% |
+10,700
| New | +$465K |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.